Market Overview

UPDATE: JP Morgan Downgrades CME Group to Underweight on Falling Volumes

Share:
Related CME
What A Difference A Second Makes: Are Markets Prepared For Leap Second?
Oppenheimer Offers Deep Technical Dive Into Financials, Says Goldman, JP Morgan, Morgan Stanley 'Top Buy Ideas'
Give Yourself A Raise With These 5 Hot Income Stocks (Investor's Business Daily)

JP Morgan reduced its rating on CME Group (NASDAQ: CME) from Neutral to Underweight and reduced its price target from $56.50 to $54.

JP Morgan said, "We see a disconnect between the fundamentals in CME's core business and the price appreciation and valuation of its stock. While we see the opportunities for both OTC clearing revenue and the migration to listed trading for interest rates, we feel that those opportunities could develop over a longer period of time, leaving investors to focus on the market-condition-driven deterioration in volumes. While a special dividend provides support to the stock, we see the potential for downside with limited upside over the next 6-12 months."

CME Group closed at $59.35 on Thursday.

Latest Ratings for CME

DateFirmActionFromTo
May 2015Evercore PartnersUpgradesHoldBuy
May 2015BarclaysMaintainsEqual-weight
May 2015Deutsche BankMaintainsBuy

View More Analyst Ratings for CME
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Downgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (CME)

Around the Web, We're Loving...